The UK’s FIP Advice Team has released new antiviral drug treatment guidelines for feline infectious peritonitis (FIP).
A major change is introduction of twice daily dosing of oral GS-441524, based on the observation that inter-cat variations in drug absorption and metabolism might account for some of the treatment failures that are seen with once daily
Now that Canadian veterinarians can legally import antiviral drugs for treatment of feline infectious peritonitis (FIP), there’s no (good) reason for people in Canada to be sourcing these drugs on the black market. However, there are still many countries (e.g. the US) where it’s still tough or impossible to get these drugs legally, so
A fatal Alaskapox virus infection in a person in (unsurprisingly) Alaska has once again focused a lot of attention on this rather obscure virus. When I last wrote about Alaskapox virus in 2020, we had a lot of unanswered questions about it, yet today we’re not that much further along, largely because this virus
Great news for Canadian veterinarians, cat owners and cats: We now have legal access to drugs that can treat feline infectious peritonitis (FIP), a disease that’s historically been considered almost invariably fatal in cats, prior to the discovery of these very treatments.
I’ll keep this short (-ish… since Moe keeps complaining about my long posts).
In the first two parts of this series, I explained a lot of the changes that have been made to the CLSI veterinary antimicrobial susceptibility testing guidelines, specifically those related to staphylococci and Enterobacterales (which includes E. coli and friends). There’s less to say about Pseudomonas, but these changes will impact our
Diagnostic testing is a cornerstone of veterinary medicine that helps us optimize patient care, but there’s a lot of science behind it that people often forget. We collect a sample, send it off for testing and magically get the results, often without putting a lot of thought into what happens at the lab. Labs (should)
I spend a lot of time talking about antimicrobial misconceptions and dogmas. They are a big issue, because they often lead to unnecessary or excessive duration of antimicrobial use, use of more invasive routes of administration (e.g. intravenous over oral), or use of higher-tier antimicrobials than necessary.
I’ll just address one of these misconceptions today:
Next in the World AMR Awareness Week (WAAW) series is a recycled post about our cat Rumple from this past summer. It’s not just because I’m lazy. It’s largely because it’s a great topic and an issue for which there’s a lot of unnecessary antibiotic use (especially in cats).
Rumple’s an indoor-outdoor cat that
Back in August, I wrote about a high-profile but poorly described “outbreak” of feline infectious peritonitis (FIP) in cats in Cyprus. Now, a preprint publication (Attipa et al. 2023) has come out with some interesting information, but lots of questions still remain. That’s the nature of emerging diseases – a single report
A recent case report in the journal American Journal of Case Reports (Garza et al. 2023) implicated a pet cat as the cause of a person’s recurrent Clostridium (Clostridioides) difficile infection.
Spoiler alert: it’s a pretty weak link. They have a catchy title: “Look what the cat dragged in! Recurrent Clostridioides difficile
